Evaluation of chronic opioid receptor antagonist effects upon weight and intake measures in lean and obese Zucker rats

Peptides

Volumn 18, Issue 8, 1997, Pages 1201-1207

  Cole, Jessica L ^a   Berman, Nathaniel ^a   Bodnar, Richard J ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Body weight; Delta receptor; Feeding; Genetic obesity; Kappa receptor; Mu receptor; Opioids; Zucker rat

Indexed keywords

BETA FUNALTREXAMINE; DELTA OPIATE RECEPTOR ANTAGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; LEUCINE ENKEPHALIN[2 DEXTRO ALANINE 6 CYSTEINE]; MU OPIATE RECEPTOR ANTAGONIST; NALOXONAZINE; NALTRINDOLE; NORBINALTORPHIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; FOOD INTAKE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MICROINJECTION; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT;

ANIMALS; BODY WEIGHT; DEPRESSION, CHEMICAL; EATING; MALE; OBESITY; RATS; RATS, ZUCKER; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

ANIMALIA; CAFETERIA;

EID: 0031458242     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00074-0     Document Type: Article

References (46)

1. Arjune D., Bodnar R. J. Suppression of nocturnal, palatable and glucoprivic intake in rats by the kappa opioid antagonist, nor-binaltorphamine. Brain Res. 534:1990;313-316.
2. Arjune D., Bowen W. D., Bodnar R. J. Ingestive behavior following central [D-Ala2,Leu5,Cys6]-enkephalin (DALCE), a short-acting agonist and long-acting antagonist at the delta opioid receptor. Pharmacol. Biochem. Behav. 39:1991;429-436.
3. Arjune D., Standifer K. M., Pasternak G. W., Bodnar R. J. Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions. Brain Res. 535:1990;101-109.
4. Beck B., Burlet A., Nicolas J.-P. Galanin in the hypothalamus of fed and fasted lean and Zucker rats. Brain Res. 623:1993;124-130.
5. Beck B., Burlet A., Nicolas J. P., Burlet C. Hypothalamic neuropeptide Y (NPY) in obese Zucker rats Implications in feeding and sexual behaviors . Physiol. Behav. 47:1990;449-453.
6. Beczkowska I. W., Bowen W. D., Bodnar R. J. Central opioid receptor subtype antagonists differentially alter sucrose and deprivation-induced water intake in rats. Brain Res. 589:1992;291-301.
7. Bodnar, R. J. Opioid receptor subtype antagonists and ingestion. In: Cooper, S. J.; Clifton, P. J., Eds. Drug receptor subtypes and ingestive behaviour. Academic Press: London; 1996:127-146.
8. Brands B. J., Thornhill J. A., Hirst M., Gowdey C. W. Suppression of food intake and body weight by naloxone in rats. Life Sci. 24:1979;1773-1778.
9. Cole J. L., Leventhal L., Pasternak G. W., Bowen W. D., Bodnar R. J. Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats. Brain Res. 678:1995;168-176.
10. Cooper, S. J.; Jackson, A.; Kirkham, T. C.; Turkish, S. Endorphins, opiates and food intake. In: Rodgers, R. J.; Cooper, S. J., Eds. Endorphins, opiates and behavioral processes. John Wiley and Sons: New York; 1988:143-186.
11. Gibson M. J., Liotta A. S., Krieger D. T. The Zucker fa/fa rat Absent circadian corticosterone periodicity and elevated beta-endorphin concentrations in brain and neurointermediate pituitary . Neuropeptides. 1:1981;349-362.
12. Gosnell B. A., Grace M., Levine A. S. Effects of beta-chlornaltrexamine on food intake, body weight and opioid-induced feeding. Life Sci. 40:1987;1459-1467.
13. Gosnell, B. A.; Levine, A. S. Stimulation of ingestive behaviour by preferential and selective opioid agonists. In: Cooper, S. J.; Clifton, P. G., Eds. Drug receptor subtypes and ingestive behavior. Academic Press: London; 1996:147-166.
14. Gunion M. W., Peters R. H. Pituitary beta-endorphin, naloxone and feeding in several experimental obesities. Am. J. Physiol. 241:1981;R173-R184.
15. Jhanwar-Uniyal M., Awad I. R., Gearhart G. M., Finkelstein J. A., Leibowitz S. F. Higher alpha-noradrenergic receptors in paraventricular nucleus of obese Zucker rats Decline after food deprivation . Pharmacol. Biochem. Behav. 40:1991;853-859.
16. King B. M., Castellanos F. X., Kastin A. J., Berzas M., Mauk D., Olson G. A., Olson R. D. Naloxone-induced suppression of food intake in normal and hypothalamic obese rats. Pharmacol. Biochem. Behav. 11:1979;729-732.
17. B agonist, in genetically obese Zucker rats. Neuroend. 52:1990;503-510.
18. Leventhal L., Cole J. L., Rossi G. C., Pan Y. X., Pasternak G. W., Bodnar R. J. Antisense oligodeoxynucleotides against the MOR-1 clone alter weight and ingestive responses in rats. Brain Res. 719:1996;78-84.
19. Levine A. S., Grace M., Billington C. J., Portoghese P. S. Nor-binaltorphamine decreases deprivation and opioid-induced feeding. Brain Res. 534:1990;60-64.
20. Levine A. S., Grace M., Billington C. J., Zimmerman D. M. Central administration of the opioid antagonist LY255582 decreases short- and long-term food intake in rats. Brain Res. 566:1991;193-197.
21. Machidori H., Sakata T., Yoshimatsu H., Ookuma K., Fujimoto K., Kurokawa M., Yamatodani A., Wada H. Zucker obese rats Defect in brain histamine control of feeding . Brain Res. 590:1992;180-186.
22. Maggio C. A., Haraczkiewicz E., Vasselli J. R. Diet composition alters the satiety effect of cholecystokinin in lean and obese Zucker rats. Physiol. Behav. 43:1988;485-491.
23. Mann P. E., Pasternak G. W., Hahn E. F., Curreri G., Lubin E., Bodnar R. J. Comparison of chronic naloxone and naloxonazine effects upon food intake and body weight maintainance in rats. Neuropharm. 27:1988;349-355.
24. Margules D. L., Moisset B., Lewis M. J., Shibuya H., Pert C. B. Beta-endorphin is associated with overeating in genetically-obese mice (ob/ob) and rats (fa/fa). Science. 202:1978;988-991.
25. Marks-Kaufman R., Balmagiya T., Gross E. Modifications in food intake and energy metabolism in rats as a function of chronic naltrexone infusions. Pharmacol. Biochem. Behav. 20:1984;911-916.
26. McLaughlin C. L., Baile C. A. Decreased sensitivity of Zucker obese rats to the putative satiety peptide cholecystokinin. Physiol. Behav. 25:1980;543-548.
27. McLaughlin C. L., Baile C. A. Nalmefene decreases meal size, food and water intake and weight gain in Zucker rats. Pharmacol. Biochem. Behav. 19:1983;235-240.
28. McLaughlin C. L., Baile C. A. Feeding behavior responses of Zucker rats to naloxone. Physiol. Behav. 32:1984;755-761.
29. McLaughlin C. L., Baile C. A., Della-Fera M. A. Changes in brain met-enkephalin concentrations with peripheral CCK injections in the Zucker rat. Physiol. Behav. 36:1986;681-686.
30. McLaughlin C. L., Baile C. A., Della-Ferra M. A., Kasser T. G. Meal-stimulated increased concentrations of CCK in the hypothalamus of Zucker obese and lean rats. Physiol. Behav. 35:1985;215-220.
31. Millan M. J., Morris B. J. Long-term blockade of mu-opioid receptors suggests a role in control of ingestive behavior, body weight and core temperature in the rat. Brain Res. 450:1988;247-258.
32. Pesonen U., Huupponen R., Rouru J., Koulu M. Hypothalamic neuropeptide expression after food restriction in Zucker rats evidence of persistent neuropeptide Y gene activation . Molec. Brain Res. 16:1992;255-260.
33. 2-adrenoceptor density in forebrain areas of Zucker rats no effect of genetic obesity or antiglucocorticoid treatment . Brain Res. 574:1992;353-356.
34. Pfeiffer D. G., Nikolarakis K. E., Pfeiffer A. Chronic blockade of opiate receptors Influence on reproduction and body weights in female rats . Neuropeptides. 5:1984;279-282.
35. Recant L., Voyles N. R., Luciano M., Pert C. B. Naltrexone reduced weight gain, alters beta-endorphin and reduces insulin output from pancreatic islets of genetically obese mice. Peptides. 1:1980;309-313.
36. 3H]-naloxone binding and elevated dynorphin-A(1-8) content in the Zucker rat brain. Physiol. Behav. 43:1988;371-374.
37. 1 receptor agonist, on food intake, weight gain, plasma insulin and neuropeptide mRNA expression in obese Zucker rats. Eur. J. Pharmacol. 234:1993;191-198.
38. Routh V. H., Stern J. S., Horwitz B. A. Serotonergic activity is depressed in the ventromedial hypothalamic nucleus of 12-day old obese Zucker rats. Am. J. Physiol. 267:1994;R712-R719.
39. Sanacora G., Kershaw M., Finkelstein J. A., White J. D. Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology. 127:1990;730-737.
40. Shaw W. N., Mitch C. H., Leander J. D., Zimmerman D. M. Effect of phenylpiperidine opioid antagonists on food consumption and weight gain of the obese Zucker rat. J. Pharmacol. Exp. Ther. 253:1990;85-89.
41. Shimomura Y., Oku J., Glick Z., Bray G. A. Opiate receptors, food intake and obesity. Physiol. Behav. 28:1982;441-445.
42. Strohmayer A. J., Greenberg D. Devazepide alters meal patterns in lean, but not obese, male Zucker rats. Physiol. Behav. 56:1994;1037-1039.
43. Thornhill J. A., Taylor B., Marshall W., Parent K. Central, as well as peripheral naloxone administration suppresses feeding in food-deprived Sprague-Dawley and genetically obese Zucker rats. Physiol. Behav. 29:1982;841-846.
44. Tsujii S., Nakai Y., Koh T., Takahashe H., Usui T., Ikeda H., Matsuo T., Imura H. Effects of food deprivation on opioid receptor binding in the brain of lean and fatty Zucker rats. Brain Res. 399:1986;200-203.
45. Ukai M., Holtzman S. G. Effects of beta-funaltrexamine on ingestive behaviors in the rat. Eur. J. Pharmacol. 153:1988;161-165.
46. Yang Z.-J., Meguid M. M. LHA dopaminergic activity in obese and lean Zucker rats. Neuroreport. 6:1995;1191-1194.